Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-18-002521
Filing Date
2018-03-02
Accepted
2018-03-02 17:24:32
Documents
13

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b4030218_aytubioscience.htm 424B4 2254605
2 GRAPHIC image_001.jpg GRAPHIC 3494
3 GRAPHIC cover.jpg GRAPHIC 115488
4 GRAPHIC image_002.jpg GRAPHIC 71160
5 GRAPHIC image_003.jpg GRAPHIC 5035
6 GRAPHIC image_004.jpg GRAPHIC 24348
7 GRAPHIC image_005.jpg GRAPHIC 34179
8 GRAPHIC image_006.jpg GRAPHIC 30658
9 GRAPHIC image_007.jpg GRAPHIC 50908
10 GRAPHIC image_008.jpg GRAPHIC 15371
11 GRAPHIC image_009.jpg GRAPHIC 9987
12 GRAPHIC image_010.jpg GRAPHIC 42502
13 GRAPHIC image_011.jpg GRAPHIC 16254
  Complete submission text file 0001213900-18-002521.txt   2834987
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B4 | Act: 33 | File No.: 333-222994 | Film No.: 18663410
SIC: 2834 Pharmaceutical Preparations